Intellectual disability-balding-patella luxation-acromicria syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3041OMIM:300977Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Intellectual disability-balding-patella luxation-acromicria syndrome, also known as Biemond syndrome type II, is an extremely rare genetic condition characterized by a distinctive combination of features affecting multiple body systems. The syndrome was first described by Biemond and is defined by intellectual disability (ranging from mild to moderate), premature balding or alopecia, recurrent dislocation (luxation) of the patella (kneecap), and acromicria — a condition in which the hands and feet are abnormally small. Additional features may include short stature and obesity. The skeletal system is notably affected, with the patellar instability causing knee problems and the small extremities reflecting underlying skeletal dysplasia. Neurological involvement manifests primarily as cognitive impairment. The condition has been reported in very few families in the medical literature, making it one of the rarest described syndromes. There is no specific cure or targeted therapy for this syndrome. Management is supportive and symptomatic, potentially including special education services for intellectual disability, orthopedic interventions for patellar luxation, and monitoring of growth and development. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Metatarsus adductusHP:0001840Thoracic kyphosisHP:0002942Thoracolumbar scoliosisHP:00029442-3 toe syndactylyHP:00046914-5 toe syndactylyHP:0004692Flat occiputHP:0005469Lumbar kyphosis in infancyHP:0008414Abnormal antihelix morphologyHP:0009738Flexion contracture of digitHP:0030044
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Intellectual disability-balding-patella luxation-acromicria syndrome.

View clinical trials →

No actively recruiting trials found for Intellectual disability-balding-patella luxation-acromicria syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Intellectual disability-balding-patella luxation-acromicria syndrome community →

No specialists are currently listed for Intellectual disability-balding-patella luxation-acromicria syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Intellectual disability-balding-patella luxation-acromicria syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Intellectual disability-balding-patella luxation-acromicria syndromeForum →

No community posts yet. Be the first to share your experience with Intellectual disability-balding-patella luxation-acromicria syndrome.

Start the conversation →

Latest news about Intellectual disability-balding-patella luxation-acromicria syndrome

No recent news articles for Intellectual disability-balding-patella luxation-acromicria syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Intellectual disability-balding-patella luxation-acromicria syndrome

What is Intellectual disability-balding-patella luxation-acromicria syndrome?

Intellectual disability-balding-patella luxation-acromicria syndrome, also known as Biemond syndrome type II, is an extremely rare genetic condition characterized by a distinctive combination of features affecting multiple body systems. The syndrome was first described by Biemond and is defined by intellectual disability (ranging from mild to moderate), premature balding or alopecia, recurrent dislocation (luxation) of the patella (kneecap), and acromicria — a condition in which the hands and feet are abnormally small. Additional features may include short stature and obesity. The skeletal sys

How is Intellectual disability-balding-patella luxation-acromicria syndrome inherited?

Intellectual disability-balding-patella luxation-acromicria syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Intellectual disability-balding-patella luxation-acromicria syndrome typically begin?

Typical onset of Intellectual disability-balding-patella luxation-acromicria syndrome is childhood. Age of onset can vary across affected individuals.